Home > PS Ratio > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
PS (Price/Sales) Ratio

The Current P/S Ratio of SHUKRA PHARMACEUTICALS is 58.97.

Share Price ₹47.3Jan 09,2026
Market Cap ₹2,071.3 Cr
Sales-TTM₹35.1 CrTTM-Standalone Results
Price/Sales58.97xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results

Definition & Calculation of PS (Price/Sales) ratio of SHUKRA PHARMACEUTICALS

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of SHUKRA PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹2,071.3 Cr] as on Jan 09,2026

(/) Sales [ ₹35.1 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 58.97x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay '58.97 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of SHUKRA PHARMACEUTICALS !

The chart below summarizes the trend in P/S Ratio of SHUKRA PHARMACEUTICALS over the last five years.

Historical PS (Price/Sales) ratio chart of SHUKRA PHARMACEUTICALS


PS Ratio Performance Analysis for SHUKRA PHARMACEUTICALS

- SHUKRA PHARMACEUTICALS 's latest p/e ratio is 58.97x.

- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.11x.

- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 29.36x.

- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0.31x.


How does SHUKRA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
SHUKRA PHARMACEUTICALS 35.158.972,071.3
SUN PHARMACEUTICAL INDUSTRIES LTD54,964.07.55415,073.0
DIVIS LABORATORIES LTD10,029.017.51175,657.0
CIPLA LTD28,349.64.18118,431.0
TORRENT PHARMACEUTICALS LTD12,248.010.95134,121.0
DR REDDYS LABORATORIES LTD34,310.02.94100,944.0
MANKIND PHARMA LTD13,576.96.6990,806.8
ZYDUS LIFESCIENCES LTD24,493.93.6890,052.9
LUPIN LTD24,750.74.0399,648.4
AUROBINDO PHARMA LTD32,514.52.1469,609.1
ABBOTT INDIA LTD6,714.48.8759,589.2

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHUKRA PHARMACEUTICALS 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.14x
Max industry PS 58.97x
Median industry PS 6.69x
Average industry PS 11.59x



You may also like the below Video Courses